Comprehensive Extractables and Leachables Analysis for Drug Development

4 August 2016

The CMC department within Drug Development Services at LGC provide a range of services for clients looking to identify and quantify compounds present in drug packaging and delivery systems and the likelihood of clinical exposure to these, as well as stability and storage testing. Learn how the department investigates extractables and leachables using inorganic and organic analyses, such as ICP-MS and ICP-OES, GC and LC methods, respectively. Hear how the department is working to develop its screening methods to provide more comprehensive data to help clients make informed decisions about future work and the submissions they make to regulators.